Prostate cancer statistics, 2025
CA: A Cancer Journal for Clinicians · 2025-12 · 75 (6) · 485-497
DOI: 10.3322/caac.70028 ↗Kurz gefasst
Fachartikel in der Zeitschrift CA: A Cancer Journal for Clinicians, online erschienen am 02.09.2025. Verfasst von Tyler B Kratzer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 134-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Prostate cancer is the most common cancer among men in the United States, and the incidence of advanced disease is increasing rapidly. This article provides an overview of prostate cancer occurrence using population‐based incidence and mortality data from the National Cancer Institute and the Centers for Disease Control and Prevention. Prostate cancer incidence trends have reversed from a decline of 6.4% per year during 2007 through 2014 to an increase of 3.0% annually during 2014 through 2021. The increasing trend is confined to distant‐stage disease in men younger than 55 years and to regional/distant‐stage disease in men aged 55–69 years but includes early stage disease in men aged 70 years and older. Over the past decade of data, distant‐stage disease has increased by 2.6% annually in men younger than 55 years, 6.0% annually in men aged 55–69 years, and 6.2% annually in men aged 70 years and older. American Indian/Alaska Native, Asian American/Pacific Islander, and Hispanic men are less likely than Black and White men to be diagnosed with localized disease (64%–67% vs. 71%–72%). Compared with White men, American Indian/Alaska Native men have 12% higher prostate cancer mortality despite 13% lower incidence, whereas Black men have double the prostate cancer mortality, with 67% higher incidence. In summary, continued increases in the diagnosis of advanced prostate cancer and persistent racial disparities underscore the need for redoubled efforts to optimize early detection while limiting overdiagnosis and to understand and address barriers to equitable outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA.
ORCID-Profile: Tyler B Kratzer, Natalia Mazzitelli, Jessica Star, William L Dahut, Rebecca L Siegel
Zitieren
APA
Kratzer, T. B., Mazzitelli, N., Star, J., Dahut, W. L., Jemal, A., & Siegel, R. L. (2025). Prostate cancer statistics, 2025. CA: A Cancer Journal for Clinicians, 75(6), 485-497. https://doi.org/10.3322/caac.70028
Vancouver
Kratzer TB, Mazzitelli N, Star J, Dahut WL, Jemal A, Siegel RL. Prostate cancer statistics, 2025. CA: A Cancer Journal for Clinicians. 2025;75(6):485-497. doi:10.3322/caac.70028
BibTeX
@article{Kratzer2025,
author = {Kratzer, Tyler B and Mazzitelli, Natalia and Star, Jessica and Dahut, William L and Jemal, Ahmedin and Siegel, Rebecca L},
title = {Prostate cancer statistics, 2025},
journal = {CA: A Cancer Journal for Clinicians},
year = {2025},
volume = {75},
number = {6},
pages = {485--497},
doi = {10.3322/caac.70028}
}
EUVIMED